Scarica l'app Stockscreener
4.455
8.52%
-0.415
Voyager Therapeutics Inc Azioni (VYGR) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
14.75%
15.34
|
13.37 | 5.20 | 6.473 | 6.278 |
Operating Expenses
|
2.98%
45.27
|
43.96 | 41.83 | 41.17 | 44.58 |
| Benefits Costs and Expenses |
3.83%
42.75
|
41.17 | 38.57 | 37.46 | 40.18 |
| Costs And Expenses |
3.83%
42.75
|
41.17 | 38.57 | 37.46 | 40.18 |
| Operating Income/Loss |
2.16%
-29.93
|
-30.59 | -36.62 | -34.69 | -38.30 |
| Nonoperating Income/Loss |
9.69%
2.515
|
2.785 | 3.258 | 3.709 | 4.396 |
| Income/Loss From Continuing Operations Before Tax |
1.41%
-27.42
|
-27.81 | -33.37 | -30.98 | -33.90 |
| Income Tax Expense/Benefit |
89.16%
0.009
|
0.083 | 0.015 | 0.037 | 0.584 |
| Income/Loss From Continuing Operations After Tax |
1.67%
-27.43
|
-27.89 | -33.38 | -31.02 | -34.49 |
|
Net Income/Loss
|
1.67%
-27.43
|
-27.89 | -33.38 | -31.02 | -34.49 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.86%
0.0831
|
58.80 | 58.67 | 58.35 | 0.1031 |
| Diluted Average Shares |
99.86%
0.0831
|
58.80 | 58.67 | 58.35 | 0.1031 |
| Basic Earnings Per Share |
0.00%
-0.47
|
-0.47 | -0.57 | -0.53 | -0.60 |
| Diluted Earnings Per Share |
0.00%
-0.47
|
-0.47 | -0.57 | -0.53 | -0.60 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):